Mt

Microneedle & Transdermal Delivery

011

From pre-IND stages through commercialization, we have the expertise to help navigate the complex regulatory environment for microbiological control of microneedles and other novel transdermal products.

Ways we can help:

  • Identifying appropriate microbial control specifications (CDER/CBER/CDRH).
  • Pre IND communications.
  • EOP2 meetings and planning for commercialization.
  • Negotiating specifications/release testing.
  • Document preparation.
  • Generating product-specific microbial data.
  • Applying USP methods/suitability studies.
  • Method development/validation.
  • Marketing submissions.
Download Brochure

Annex 1 revision experts.

Our consultants are highly-recognized for their Annex 1 knowledge and expertise. We provide a plan forward through Annex 1 updates, today and into the future.